Yuanfei Deng
Foshan, 528000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.
Journal: Cancer letters
Published: February 27, 2026
Saquinavir induces pyroptosis through the OTUD5-JAK1-GSDME axis in hepatocellular carcinoma.
Journal: Free radical biology & medicine
Published: December 16, 2025
The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.
Journal: Oncogene
Published: November 06, 2025
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.
Journal: Oncogene
Published: February 26, 2025
Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.
Journal: Experimental cell research
Published: September 27, 2024
METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.
Journal: Pharmacological research
Published: September 21, 2024
Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
Journal: Cancer medicine
Published: August 09, 2023
ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression.
Journal: Frontiers in pharmacology
Published: January 20, 2022
A SIX1 degradation inducer blocks excessive proliferation of prostate cancer.
Journal: International journal of biological sciences
Published: October 08, 2021
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.
Journal: Cell death & disease
Published: June 23, 2021
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2021
Last Updated: 09/26/2026